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Abstract
Evidence-based medicine employs expert opinion and clinical data to inform clinical decision making. The objective of this
study is to determine whether it is possible to complement these sources of evidence with information about physician
‘‘group intelligence’’ that exists in electronic health records. Specifically, we measured laboratory test ‘‘repeat intervals’’,
defined as the amount of time it takes for a physician to repeat a test that was previously ordered for the same patient. Our
assumption is that while the result of a test is a direct measure of one marker of a patient’s health, the physician’s decision
to order the test is based on multiple factors including past experience, available treatment options, and information about
the patient that might not be coded in the electronic health record. By examining repeat intervals in aggregate over large
numbers of patients, we show that it is possible to 1) determine what laboratory test results physicians consider ‘‘normal’’, 2)
identify subpopulations of patients that deviate from the norm, and 3) identify situations where laboratory tests are over-
ordered. We used laboratory tests as just one example of how physician group intelligence can be used to support evidence
based medicine in a way that is automated and continually updated.
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Introduction
In evidence-based medicine (EBM), clinical practice guidelines
are driven by expert consensus, which is typically based on review
of the literature, clinical experience, and outcomes analyses [1,2].
A major challenge of EBM is the effort and cost needed to keep the
knowledge of clinical practice up to date across an ever-widening
array of diagnostic and therapeutic options [3]. One way to
approach this problem is through analysis of the large amounts of
data collected in electronic health records (EHR) [4]. Usually the
variable being examined in these datasets is a patient outcome,
such as survival [5]. However, in this study we will demonstrate
that EHRs not only contain information about patient outcomes,
but they also provide insight to providers’ knowledge of their
patients’ state of health, which can also be used in generating EBM
guidelines. We will do this in the context of laboratory tests.
Instead of looking at the results of the tests, we will examine when
physicians ordered the tests. Whereas the result of a test is a direct
measure of one maker of a patient’s health, a physician’s decision
to order a test is based on multiple factors including past
experience, available treatment options, and information about
the patient that might not be coded in the EHR.
Specifically, we will measure laboratory test ‘‘repeat interval’’,
defined as the amount of time it takes for a physician to repeat a
test that was previously ordered for the same patient. For
example, if a white blood cell count (WBC) test is ordered for a
patient, and the next time that patient has a WBC test is seven
days later, then the repeat interval is seven days. The physician
ordering the repeat test is not necessarily the same person who
ordered the previous test, but could presumably access the result
of the previous test through the EHR. By examining these
repeat intervals in aggregate over large numbers of patients, we
can quantify physician behavior and observe how it varies under
different conditions. To demonstrate how this can be used for
EBM, we will use the laboratory test repeat intervals from the
EHRs of two large and independent hospitals in the Boston area
to answer three questions: Firstly, can collective physician
laboratory test-ordering behavior, which we call physician
‘‘group intelligence’’, be used to define what it means for a
laboratory test result to be ‘‘normal’’? Secondly, can subpop-
ulations of patients be identified when their physicians’ behavior
differs from the norm? Finally, can physician group intelligence
be used to identify situations where laboratory tests are over-
ordered?
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Table 1. Summary of repeat intervals for 97 laboratory tests.
Laboratory Test (LOINC Name) LOINC Code
Median
Repeat
Interval
Min Bin
Median
Repeat
Interval
Max Bin
Median
Repeat
Interval
Ratio Bin
Median
Repeat
Interval
StDev
Repeat
Interval Entropy Category
pH SerPl-sCnc 2753-2 0.121 0.059 0.150 2.541 111.8 0.722 BGB
Base Excess BldA-sCnc 1925-7 0.122 0.078 0.176 2.248 144.1 0.881 BG
O2 Satn from pO2 Fr Bld 2713-6 0.123 0.065 0.176 2.691 135.6 0.881 BGB
pO2 Bld Qn 11556-8 0.124 0.027 0.168 6.205 117.4 0.811 BGB
pCO2 Bld Qn 11557-6 0.124 0.063 0.150 2.400 127.5 0.610 BGB
Inhaled O2 rate 3151-8 0.136 0.059 0.235 3.976 43.0 1.279 GB
Ca-I Bld-sCnc 1994-3 0.157 0.082 0.169 2.068 156.8 0.286 BGB
HCO3 Bld-sCnc 1959-6 0.208 0.118 0.253 2.147 76.8 0.881 BG
Ca-I SerPl-sCnc 1995-0 0.218 0.167 0.258 1.550 169.2 0.722 BG
Gentamicin SerPl-mCnc 35668-3 0.379 0.076 2.418 31.945 199.4 1.915 BG
CK MB SerPl EIA-cCnc 6773-6 0.402 0.342 0.472 1.379 368.9 0.971 BGB
CK/CK MB SerPl-cRto 2158-4 0.424 0.383 0.463 1.208 337.7 0.934 GBGB
Osmolality SerPl Qn 2692-2 0.444 0.278 0.850 3.060 269.4 1.458 GB
Troponin T SerPl-mCnc 6598-7 0.485 0.440 0.539 1.224 116.6 0.000 BG
CK SerPl-cCnc 2157-6 0.642 0.424 1.017 2.402 400.8 0.881 GB
Troponin I SerPl-mCnc 10839-9 0.741 0.439 19.857 45.244 284.7 1.882 GB
aPTT Plas Qn 5898-2 0.927 0.378 1.270 3.356 346.7 1.141 GB
Potassium SerPl-sCnc 2823-3 0.958 0.444 0.987 2.224 291.7 0.286 BGB
Vancomycin SerPl-mCnc 20578-1 0.974 0.144 1.519 10.519 174.3 0.848 BG
Magnesium SerPl-sCnc 11554-3 0.977 0.483 1.042 2.157 284.7 0.286 GB
CO2 SerPl-sCnc 2028-9 0.988 0.408 1.144 2.801 311.5 0.748 BGB
Glucose SerPl-mCnc 6777-7 0.996 0.292 24.978 85.437 332.3 2.528 GB
Sodium SerPl-sCnc 2951-2 0.997 0.426 1.846 4.329 310.6 0.748 BGB
Anion Gap3 SerPl-sCnc 10466-1 1.000 0.829 1.015 1.224 307.1 0.000 BGB
Hgb Bld-mCnc 718-7 1.010 0.391 33.962 86.865 324.8 2.461 BG
Hct Fr Bld Auto 4544-3 1.026 0.490 40.188 81.970 336.9 2.595 BG
PT PPP Qn 5902-2 1.035 0.974 3.119 3.202 332.6 1.054 GBG
Chloride SerPl-sCnc 2075-0 1.049 0.600 1.876 3.127 330.5 0.748 BGB
INR PPP Qn 6301-6 1.053 0.982 6.998 7.127 235.8 1.154 GBG
BUN SerPl-mCnc 3094-0 1.068 0.722 2.994 4.145 338.5 1.439 BGB
Creat SerPl-mCnc 2160-0 1.090 0.892 2.193 2.460 333.4 0.993 BGB
RDW RBC Auto-Rto 788-0 1.103 0.987 42.922 43.495 337.1 1.871 GB
MCH RBC Qn Auto 785-6 1.204 1.052 2.788 2.650 351.9 0.992 GBG
MCV RBC Qn Auto 787-2 1.205 1.052 2.754 2.618 347.8 1.076 GBG
WBC # Bld Auto 6690-2 1.213 0.769 15.403 20.037 351.6 1.923 BGB
Phenytoin SerPl-mCnc 3968-5 1.217 1.122 1.944 1.733 201.3 0.610 GBGB
RBC # Bld Auto 789-8 1.217 0.796 43.963 55.242 347.5 2.361 BG
Platelet # Bld Auto 777-3 1.225 0.735 7.033 9.573 349.8 2.009 BGB
MCHC RBC Auto-mCnc 786-4 1.231 1.040 2.024 1.947 355.6 0.993 BGB
Calcium SerPl-sCnc 2000-8 1.644 0.736 35.068 47.640 390.6 2.458 BG
Digoxin SerPl-mCnc 10535-3 1.960 1.001 3.143 3.139 263.6 1.157 GB
Phosphate SerPl-mCnc 2777-1 1.965 1.003 5.594 5.574 384.3 1.971 BGB
Lipase SerPl-cCnc 3040-3 1.974 0.999 5.031 5.038 427.1 1.839 BGB
Metamyelocytes Fr Bld Manual 740-1 2.426 1.053 4.111 3.902 289.6 1.720 GB
Amylase SerPl-cCnc 1798-8 2.446 0.989 10.447 10.564 529.3 2.204 BGB
Myelocytes Fr Bld Manual 749-2 2.456 1.043 4.278 4.101 277.0 1.720 GB
Neuts Seg Fr Bld Manual 769-0 2.673 1.067 5.905 5.536 365.7 2.195 BGB
Monocytes Fr Bld Manual 744-3 2.760 1.092 4.041 3.699 358.7 1.788 BGB
Basophils Fr Bld Manual 707-0 2.776 2.021 6.968 3.448 359.8 1.076 BG
Lymphocytes Fr Bld Manual 737-7 2.790 1.060 11.269 10.627 390.8 2.409 BGB
Physician Group Intelligence
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Table 1. Cont.
Laboratory Test (LOINC Name) LOINC Code
Median
Repeat
Interval
Min Bin
Median
Repeat
Interval
Max Bin
Median
Repeat
Interval
Ratio Bin
Median
Repeat
Interval
StDev
Repeat
Interval Entropy Category
Eosinophil Fr Bld Manual 714-6 2.846 1.886 5.990 3.176 367.6 1.713 BG
Neuts Band # Bld Manual 763-3 2.924 1.028 8.065 7.842 172.1 2.285 GB
Estradiol SerPl-mCnc 2243-4 2.988 1.051 13.929 13.248 232.2 1.981 GBG
Atypical Lymphs Fr Bld Manual 735-1 3.040 2.123 5.901 2.780 416.0 1.739 BG
Neuts Band Fr Bld Manual 764-1 3.894 1.020 42.122 41.291 396.5 2.771 GBGB
Cyclosporin Bld-mCnc 3520-4 5.970 2.974 11.236 3.778 92.6 1.533 GB
LDH SerPl-cCnc 2532-0 8.132 1.031 33.894 32.889 368.5 2.984 BGB
HCG SerPl-sCnc 2119-6 8.895 2.992 276.063 92.256 531.9 2.704 GBG
Globulin Ser-mCnc 2336-6 10.912 1.037 28.033 27.038 458.4 2.409 BGB
Prot SerPl-mCnc 2885-2 15.105 0.982 102.826 104.717 448.8 2.566 BG
Retics/100 RBC Fr 4679-7 17.717 6.372 41.006 6.436 516.0 2.522 BGB
Bilirub SerPl-mCnc 1975-2 19.547 0.956 47.202 49.362 442.4 2.458 GB
Urate SerPl-mCnc 3084-1 20.169 1.050 44.928 42.789 415.0 2.823 BGB
Albumin SerPl-mCnc 1751-7 20.757 1.118 128.127 114.598 444.0 3.141 BG
ALP SerPl-cCnc 6768-6 27.978 1.289 70.348 54.580 443.2 2.561 GB
Basophils Fr Bld Auto 706-2 28.043 2.110 52.266 24.774 410.5 2.804 BGB
Eosinophil Fr Bld Auto 713-8 28.081 2.555 52.915 20.711 410.3 2.522 BGB
ALT SerPl-cCnc 1742-6 28.414 1.110 58.151 52.369 430.1 2.361 BGB
Eosinophil # Bld Auto 711-2 28.920 2.501 60.021 24.002 409.5 2.746 BGB
Basophils # Bld Auto 704-7 29.528 4.877 52.957 10.858 411.1 2.571 BGB
AST SerPl-cCnc 1920-8 30.291 1.055 78.035 73.977 431.8 2.461 BGB
Monocytes Fr Bld Auto 5905-5 34.410 5.740 56.119 9.776 464.5 2.384 BGB
Neutrophils Fr Bld Auto 770-8 34.686 1.885 92.702 49.168 468.3 3.141 GB
Lymphocytes Fr Bld Auto 736-9 34.826 1.797 114.231 63.560 464.9 2.946 BG
Neutrophils # Bld Auto 752-6 34.932 1.768 75.975 42.971 457.9 2.461 BGB
Monocytes # Bld Auto 742-7 35.744 3.636 83.958 23.090 470.4 2.358 BGB
Lymphocytes # Bld Auto 731-0 37.134 1.963 99.138 50.498 462.7 2.622 BG
PMV Bld Qn 28542-9 37.998 10.019 67.001 6.687 254.6 2.119 BGB
Sp Gr Ur Qn Strip 5811-5 49.284 33.625 81.578 2.426 581.0 1.782 GBGB
RBC # UrnS HPF 5808-1 49.988 12.815 83.504 6.516 619.8 2.115 GB
pH Ur Strip-sCnc 5803-2 51.020 36.494 70.001 1.918 594.1 1.295 BGB
Trigl SerPl-mCnc 2571-8 108.380 42.058 225.953 5.372 498.3 2.121 GB
ESR Bld Qn Westrgrn 4537-7 125.983 21.147 246.166 11.641 672.5 2.085 GB
Cholest SerPl-mCnc 2093-3 127.327 1.059 204.759 193.346 503.5 1.933 BGB
Hgb A1c Fr Bld 4548-4 132.945 113.022 216.175 1.913 328.8 1.076 GB
Mean Glucose Bld gHb Est-mCnc 27353-2 137.837 120.280 266.906 2.219 325.6 1.076 GB
Ferritin SerPl-mCnc 2276-4 151.261 34.569 213.974 6.190 622.9 1.457 GB
T4 SerPl-mCnc 3026-2 154.974 47.040 202.118 4.297 629.6 1.357 BGB
Iron SerPl-mCnc 2498-4 160.883 83.993 266.211 3.169 628.1 1.846 BGB
TIBC SerPl-mCnc 2500-7 166.066 27.024 248.118 9.182 649.0 1.717 BG
TSH SerPl-aCnc 3016-3 232.133 55.991 368.103 6.574 578.2 1.579 BGB
Cholest/HDLc SerPl-mRto 9830-1 247.117 131.251 367.034 2.796 348.0 1.234 GB
VLDLc SerPl-mCnc 2092-5 253.763 175.665 363.871 2.071 563.9 0.993 GB
B-LP SerPl Calc-sCnc 14815-5 264.197 166.951 346.086 2.073 578.8 0.881 BGB
LDLc SerPl-mCnc 2090-9 273.672 172.881 343.069 1.984 517.4 0.881 BGB
HDLc SerPl-mCnc 2086-7 276.331 146.957 370.070 2.518 528.6 1.188 BG
PSA SerPl-mCnc 2857-1 350.024 75.940 380.037 5.004 392.9 1.076 BGB
Listed for each test are the LOINC (Logical Observation Identifiers Names and Code) name and code; the median repeat interval and standard deviation for all 100,000
repeat intervals; the minimum and maximum median repeat intervals of the 20 value bins and their ratio; the entropy; and the category: ‘‘bad-good’’ (BG), ‘‘bad-good-
bad’’ (BGB), ‘‘good-bad’’ (GB), ‘‘good-bad-good’’ (GBG), and ‘‘good-bad-good-bad’’ (GBGB). Repeat intervals are given in days.
doi:10.1371/journal.pone.0064933.t001
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Methods
Data Sources
The data used for this study were laboratory test results
contained within the Partners Research Patient Data Repository
(RPDR), a large clinical database, which combines data from
Brigham and Women’s Hospital (BWH) and Massachusetts
General Hospital (MGH) [6–8]. From an initial dataset, which
included 3,534,666 patients with 465,313,629 laboratory test
results between 1/1/1986 and 6/30/2004, we extracted two
datasets: (1) Firstly, we obtained a random sample of 100,000
repeat intervals for each of the 97 different laboratory tests listed in
Table 1 (9.7 million repeat intervals). Other laboratory tests were
excluded either because they have fewer than 100,000 occurrenc-
es, or there are known problems with how the data are recorded.
Although there are 4,926 tests in the RPDR, these 97 represent
71% of all test results because they are the ones most frequently
ordered. (2) Secondly, we obtained a random sample of 1,000,000
repeat intervals for white blood cells (WBC), which indicated the
patient age in days at the time of the tests and whether the tests
were performed in inpatient or outpatient settings. The laboratory
test dates in the RPDR are typically the dates when the results are
ready, rather than when the specimens were obtained or when the
results were read. The datasets may be requested by registration
and submission of a Data Use Agreement at http://www.i2b2.
org/Publication_Data/.
Defining normality
Reference ranges of laboratory test values are defined by
sampling a healthy population and recording the upper and lower
nth percentiles [9–11]. There are numerous challenges with
determining these ranges and in using them for clinical decision-
making. Many factors such as age, sex, and sampling bias can
influence these values; it can be difficult to identify healthy
individuals; and there is disagreement over which statistical
techniques and percentiles to use [12–15]. Furthermore, it is
unclear how useful reference ranges are in clinical decision-making
since there is a distinction between a reference limit and the value
that will actually change a physician’s clinical decision [16–19].
The latter is based not on healthy population percentiles, but
rather the types of clinical actions that are available to the
physician and his or her clinical knowledge, prior experience, and
intuition. Can we quantify this to define a new robust measure of
laboratory test value normality that reflects clinical expertise?
We defined repeat interval as the amount of time it took for
physicians to repeat the same test in the same patient. A repeat
interval consists of two tests—an initial test and a repeat test. In
this study, we looked at the relationship between the result of the
initial test and when the repeat test is ordered. To study this
relationship, for each of the 97 laboratory tests we partitioned the
100,000 repeat intervals into 20 equal-size bins based on the result
of the initial test. For example, the first bin contains the 5,000
repeat intervals with the smallest initial test result values, and the
Figure 1. Repeat intervals for 97 common laboratory tests. (a) Frequency distribution of repeat intervals for all labs. Vertical bars indicate the
boundaries used in the entropy calculations to convert repeat intervals to one of 20 discrete categories. (b) Median repeat interval for each of 97 tests.
Vertical bars indicate the 25th and 75th percentiles.
doi:10.1371/journal.pone.0064933.g001
Table 2. Entropy time periods.
Time Period Description Start (Days) Peak (Days)
1 2 hours 0.000 0.093
2 4 hours 0.103 0.170
3 8 hours 0.188 0.342
4 12 hours 0.418 0.510
5 24 hours 0.624 1.028
6 2 days 1.533 2.070
7 3 days 2.528 3.088
8 4 days 3.413 4.169
9 7 days 5.627 6.873
10 2 weeks 10.253 13.840
11 3 weeks 16.905 20.648
12 4 weeks 25.219 27.872
13 5 weeks 30.803 34.042
14 6 weeks 37.622 41.579
15 2 months 45.952 62.029
16 3 months 75.763 92.536
17 4 months 113.024 124.911
18 6 months 152.567 186.345
19 1 year 251.540 375.253
20 2 years 683.756 755.667
Listed are the start of each time period and the most common repeat interval
(peak).
doi:10.1371/journal.pone.0064933.t002
Physician Group Intelligence
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e64933
20th bin contains the 5,000 repeat intervals with the highest initial
values. For each bin, we calculated the median repeat interval
duration and the 25th and 75th percentiles. We did not use the
result of the repeat test in this study—we only measured the
amount of time that had elapsed since the initial test. Note how
this differs from traditional EBM studies, in which physicians
perform interventions, and then the patient outcomes are
measured. In this study, we start with data about the patients
(their initial laboratory test results), and then measure the
interventions chosen by their physicians (the time until the test
was repeated). In other words, we are examining the physicians as
a way of indirectly learning more about the patients.
In the first part of this study, we used repeat intervals to
examine normality in laboratory tests. Whereas laboratory test
reference ranges suggest there are only two states of patient health,
normal and abnormal, we hypothesized that repeat intervals
would reveal more subtle patterns that demonstrate the variability
among patients and the different clinical contexts in which they
are seen.
Identifying subpopulations
To determine if we can automatically identify the various
factors that can influence physician behavior, such as patient
demographics and clinical settings, we calculated the median
repeat intervals for white blood cells (WBC) for different pediatric
age groups and for inpatient vs outpatient visits. If these
subpopulations indeed represent distinct patient states that have
different clinical meaning, then differences in normative behavior
might be detectable.
Measuring informativeness
The initial test result may or may not influence when the repeat
test is ordered. We used entropy as a measure of how much the
median repeat interval varies across the 20 bins for each test. If all
20 median repeat intervals are equal, then the initial test result
provides no information towards predicting when the repeat test
will be ordered, and the entropy is therefore zero. Because
physician behavior is not being affected by the result of the test, we
hypothesize that some tests with low entropy are being over-
ordered. In contrast, tests whose initial result has a greater
influence over physician behavior will have higher entropy,
suggesting that those tests are more informative.
In order to calculate entropy, we first discretized the median
repeat interval for each laboratory test’s 20 value bins by mapping
it to one of 20 frequently observed time periods (Table 2). These
time periods were determined by combining the repeat intervals
for all 97 laboratory tests and noting from its frequency
distribution that there are approximately 20 peaks (Figure 1a).
The points between the peaks with the fewest repeat intervals were
chosen as the boundaries of the time periods. This ensured that
most repeat intervals would be near the center of a time period
rather than at the boundary, thus making the results less sensitive
to the precise location of the time period boundaries. Entropies
were then calculated using the equation -Sum[p(x)*log2(p(x))]
where p(x) is the fraction of a laboratory test’s 20 value bins whose
median repeat intervals fall within time period x. For example, if a
laboratory test has 10 value bins whose median repeat intervals fall
within time period 6 (2 days), 5 value bins that fall within time
period 4 (12 hours), and 5 value bins that fall within time period 7
Figure 2. The median repeat interval for different initial (a) WBC, (b) HDLc, (c) HbA1c, and (d) hCG values. Error bars represent the 25th
and 75th percentiles. Triangles indicate reference values for BWH (black) and MGH (gray).
doi:10.1371/journal.pone.0064933.g002
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(3 days), then the entropy is 2[0.5*log2(0.5)+0.25*log2(0.25)+
0.25*log2(0.25)] = 1.5.
Results
Table 2 and Figure 1a show that the frequency of 9.7 million
repeat intervals across the 97 tests has approximately 20 peaks,
with 24 hours being the most common, followed by 2 days, 1 year,
7 days, and 6 months. When looking at individual laboratory tests,
Table 1 and Figure 1b show that the median repeat interval can
range from as small as 3 hours for blood gases to as large as year
for cholesterol and prostate-specific antigen (PSA), with a large
variance for most tests. However, the repeat intervals can be
highly dependent on the initial value of the test as well as the
patient population and clinical setting. The next three sections
describe this relationship by testing three hypotheses.
Can physician group intelligence derive knowledge that
all physicians already know, but can be difficult to
quantify?
The reference ranges for white blood cell count (WBC) in adult
patients at BWH and MGH are 4.0–10.0 and 4.5–11.0,
respectively [6,7]. In Figure 2a, which illustrates the repeat
intervals for WBC, we can see a complex relationship between the
initial WBC value and when physicians order a second WBC test.
In general, the repeat interval for WBC is larger within the
hospital reference ranges (indicated by markers on the horizontal
axis) than outside. However, it is not a binary response. Rather,
there is a continuum, with a maximum median repeat interval of
almost two weeks at an initial WBC value of 6, and gradually
decreasing at larger or smaller values. As seen in Figure 2b and
Figure 2c, a similar pattern exists for other tests, such as high-
density lipoprotein (HDLc) and hemoglobin A1c (HbA1c), where
the largest repeat intervals occur when the initial test results are
within the hospital reference ranges, and the intervals decrease the
further outside those ranges.
The vertical bars in Figure 2 represent the 25th and 75th
percentiles of repeat intervals. The initial test result not only affects
the median repeat interval, but it also greatly affects the variance.
If we think about an initial test result being followed by a large
median repeat interval as a ‘‘good’’ test result, and an initial test
result being followed by a small median repeat interval as a ‘‘bad’’
test result, then the amount of variance corresponds to the degree
of consensus among physicians on whether a particular test result
is ‘‘good’’ or ‘‘bad’’. For example, on average, a WBC of 6 is
‘‘good’’, but the large variance means that other information is
needed to determine the patient’s state of health. At the upper
value of the reference range (10.0–11.0), the repeat interval is
smaller, but there is still large variability. However, once the WBC
is greater than 16, then there is agreement among physicians that
the result is ‘‘bad’’.
Laboratory tests can be classified according to how their repeat
intervals vary with different initial values. Although WBC is
‘‘good’’ in mid-range values and ‘‘bad’’ at the low and high
extremes (‘‘bad-good-bad’’, or ‘‘BGB’’), the repeat intervals for
HDLc are largest at high values (‘‘BG’’), and the repeat intervals
for HbA1c are largest at low values (‘‘GB’’). Table 1 shows that
most laboratory tests fall into one of these three categories, with 44
BGB tests (e.g., sodium and glucose), 19 BG tests (e.g., hematocrit
and vancomycin), and 24 GB tests (e.g., bilirubin and erythrocyte
sedimentation rate (ESR)). An exception is human chorionic
gonadotropin (hCG), which has not one, but two ‘‘good’’ states
(‘‘GBG’’) depending on whether the patient is pregnant (Figure 2d).
Although we are not arguing that this method should replace
the standard way of determining laboratory test reference ranges,
we want to highlight how remarkable it is that repeat intervals
alone, without any additional information about the patients’
health, can be used to derive physician consensus around what it
means for a test result to be ‘‘normal’’. In other words, we can use
physician group intelligence to quantify the significance of
different test results and determine the values that require
immediate action.
Can group intelligence capture the knowledge of subsets
of physicians that treat specific patient populations?
Normality as defined by physician behavior can vary greatly
with different subpopulations. In neonates, for example, the typical
WBC is higher than in adult populations. Figure 3a shows that
physicians adjust their ordering behavior for this, with a peak time
to repeat for patients less than 1 month old at a WBC of 16.3
(58,121 repeat intervals). As pediatric patients age, the ‘‘ideal’’
WBC value decreases and the maximum repeat interval increases.
For patients 1–5 months the preferred value is 12.6 (16,237 repeat
intervals), and for patients 6–23 months the preferred value is 8.9
(32,556 repeat intervals). The median time to repeat of WBC is at
a maximum of 153 days when patients are between 2–5 years old
(33,666 repeat intervals). Beyond this age, physician behavior
mimics that seen throughout adulthood (38,051 repeat intervals).
Figure 3. Factors that affect repeat interval, including (a) age and (b) inpatient vs outpatient setting. Error bars represent the 25th and
75th percentiles.
doi:10.1371/journal.pone.0064933.g003
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However, while the preferred WBC remains consistent until old
age, the repeat intervals decrease for all values in elderly
populations.
Can group intelligence identify inconsistencies in clinical
behavior and situations where the frequency of ordering
laboratory tests can be reduced?
Figure 3b shows that physician ordering behavior for WBC also
changes when patients are in an inpatient setting compared to
when they are relatively healthy in an outpatient setting. In both
cases, the maximum repeat interval is at a WBC value of about 6.
However, that interval is 22.9 hours for inpatients (365,769 repeat
intervals) and 59.1 days for outpatients (481,591 repeat intervals).
Thus, the same laboratory test result can have a dramatically
different effect on clinical decisions depending on physician’s
perceived state of the patient. It might also suggest that hospital
guidelines in an inpatient setting influence ordering behavior in
ways that are counterintuitive to physicians’ true estimate of risk.
The extent to which the initial value of a laboratory test affects
the repeat interval can indicate how informative that test is. For
nearly all 97 laboratory tests studied, the initial value does indeed
influence the repeat interval greatly (Table 1). For example, the
ratio between WBC’s best bin’s repeat interval (15.4 days) and the
worst (0.77 days) is 20-fold. There was at least a 2-fold difference
in 87 tests, a 10-fold difference in 35 tests, a 50-fold difference in
13 tests, and a more than 100-fold difference in three tests (serum
protein, albumin, and cholesterol). However, this does not tell the
full story. A test whose repeat interval is the same in nearly all
cases except for the most extreme values might provide less
information to a physician, on average, than a test whose repeat
intervals vary across the full range of values for that test. This can
be quantified using entropy.
Of the 97 tests, albumin and neutrophil fraction had the highest
observed entropies (3.141), meaning that their values, more than
any other tests, had the greatest influence on physician behavior
(Table 1). There are several explanations for why the entropy can
be low for certain laboratory tests: a) they can be routinely ordered
as part of a hospital protocol (e.g. Troponin T has zero entropy), b)
they are ordered automatically as part of a panel but are not
generally the reason for which the panel was ordered (e.g. mean
corpuscular volume (MCV) in a complete blood count (CBC) has
an entropy of 1.076), or c) they are part of a screening protocol in
which the vast majority of the test results are normal (e.g. prostate-
specific antigen (PSA) has an entropy of 1.076 because 75% of its
values are less than 3.6 and are not repeated for a one year).
Discussion
We introduced this study by enumerating three questions that
we sought to answer, at least preliminarily in a study of two large
academic hospitals. We have shown that we can use collective
physician behavior to identify normal ranges that correspond to
the published normal ranges used in these institutions but without
the threshold effect of strict limits and instead providing a smooth
function relating these values to normality and disease acuity.
Secondly, we have shown that these normative ranges are very
specific to the subpopulations being treated going from adult to
childhood and the neonatal period where the personalized
interpretation of these laboratory studies is markedly different.
Thirdly, we have shown that clinical setting, the grouping of tests
into panels, and screening guidelines can potentially lead to
overuse of laboratory tests. This automated form of EBM does
not depend on an ongoing knowledge extraction process from
experts; it is driven directly from aggregate physician behavior
as seen in EHRs. If styles of practice change, if the meaning of
particular clinical variables and their values are understood
differently over time, if additional phenotypes such as genomic
are introduced then the normative practice for the patient’s state
induced from physician behavior will automatically be changed.
This study represents only a beginning in developing an
automated application of physician group intelligence, similar
to what has been done with ‘‘crowdsourcing’’ for scientific
discovery in other fields [20–23].
There are far more sources of data that are accessible beyond
laboratory data, that are driven by physician behavior and their
integrated understanding of the patient’s state. For example, one
could examine which medications are prescribed and the number
of refills included on the initial prescriptions, which procedures are
ordered and the time intervals between them, how often follow-up
visits are scheduled, and the number of different physicians that
treat a patient. These are processes, not outcome measures, but in
aggregate represent a consensus estimate.
As in other applications of group intelligence, the use of
physician behavior rather than measured outcomes to drive the
personalization of medical practice has some obvious risks that
are built upon several underlying assumptions. The most
important of these is that physicians in aggregate are well
informed of the current state of the art. Further, over large
populations of patients, sufficient numbers of decisions can be
measured that across the varying states of patients there will be
robust characterizations of the patient subpopulations. These
assumptions can be tested empirically in the future by
comparing physician behavior at different institutions and
determining, for example, how rapidly physician behavior
changes to account for the emergence of innovative and
expert-approved clinical practices.
The intent of this study was not to draw conclusions about
specific laboratory tests. A more detailed analysis of which tests are
grouped into panels, how policies vary across different clinics, and
what changes have been seen over time would be needed for that.
Rather, our goal was to demonstrate that a wealth of often
overlooked information about physician behavior exists in EHRs,
which could provide an important source of data for future EBM
research.
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